Invention Grant
US08829015B2 Crystalline forms of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide
有权
4-甲基-N- [3-（4-甲基 - 咪唑-1-基）-5-三氟甲基 - 苯基] -3-（4-吡啶-3-基 - 嘧啶-2-基氨基） - 苯甲酰胺的结晶形式
![Crystalline forms of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide](/docs/US/2014-09-09/US08829015B2/abs.jpg.600x600.jpg)
- Patent Title: Crystalline forms of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide
- Patent Title (中): 4-甲基-N- [3-（4-甲基 - 咪唑-1-基）-5-三氟甲基 - 苯基] -3-（4-吡啶-3-基 - 嘧啶-2-基氨基） - 苯甲酰胺的结晶形式
-
Application No.: US13774433Application Date: 2013-02-22
-
Publication No.: US08829015B2Publication Date: 2014-09-09
- Inventor: Paul W. Manley , Wen-Chung Shieh , Paul Allen Sutton , Piotr “Peter” H. Karpinski , Raeann Wu , Stephanie Monnier , Jörg Brozio
- Applicant: Novartis AG
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Gregory Houghton
- Main IPC: C07D401/14
- IPC: C07D401/14 ; A01N43/54 ; A61K31/505 ; C07D239/02
![Crystalline forms of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide](/abs-image/US/2014/09/09/US08829015B2/abs.jpg.150x150.jpg)
Abstract:
Crystalline forms of 4-methyl-N-3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide free base and salts thereof are prepared by various processes.
Public/Granted literature
Information query
